Stay updated on Denosumab + PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.

Latest updates to the Denosumab + PD-1 in Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe page now shows a consolidated Locations section listing New Hampshire and North Carolina as study sites, replacing the previous separate location entries. The revision is updated to v3.3.3.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe government funding status notice has been removed from the page. The remaining content appears unchanged.SummaryDifference0.3%

- Check54 days agoChange DetectedPage content remained largely unchanged with no new sections or removed content; the latest updates appear to be routine and do not alter the core information about the NCT03620019 study.SummaryDifference0.4%

- Check83 days agoChange DetectedCore page now conveys updated operating status and a version upgrade to v3.2.0, replacing the prior v3.1.0; reflects current status and new release.SummaryDifference2%

- Check90 days agoChange DetectedPage updated from v3.0.2 to v3.1.0; a specific term (Melanoma, Cutaneous Malignant) was removed. If core content and essentials are unchanged, this is a minor revision update with terminology pruning.SummaryDifference0.1%

Stay in the know with updates to Denosumab + PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.